+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Role of Advanced Glycation End Products (Ages) and Oxidative Stress in Diabetic Retinopathy



Role of Advanced Glycation End Products (Ages) and Oxidative Stress in Diabetic Retinopathy



Current Pharmaceutical Design 14(10): 962-968




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068052233

Download citation: RISBibTeXText

DOI: 10.2174/138161208784139729


Related references

Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Current Pharmaceutical Design 14(10): 962-968, 2008

Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy. Current Pharmaceutical Biotechnology 12(3): 362-368, 2011

Molecular mechanism of diabetic retinopathy: role of advanced glycation end products(AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy. Nippon Ganka Gakkai Zasshi 109(6): 338-345, 2005

Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochimica et Biophysica Acta 1820(5): 663-671, 2012

Advanced glycation end-products induce oxidative stress through the Sirt1/Nrf2 axis by interacting with the receptor of AGEs under diabetic conditions. Journal of Cellular Biochemistry 2018, 2018

Advanced Glycation End Products (Ages) and their Receptor (Rage) System in Diabetic Retinopathy. Current Drug Discovery Technologies 3(1): 83-88, 2006

Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy. Current Drug Discovery Technologies 3(1): 83-88, 2006

Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice. Arteriosclerosis, Thrombosis, and Vascular Biology 28(8): 1432-1438, 2008

Possible role of HMG CoA reductase inhibitor on the oxidative stress induced by advanced glycation endproducts(AGEs) in vascular smooth muscle cell(VSMC) of diabetic vasculopathy. 2007

Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proceedings of the National Academy of Sciences of the United States of America 91(16): 7742-7746, 1994

Role of advanced glycation end products and activation of PKC in diabetic retinopathy. Nihon Rinsho. Japanese Journal of Clinical Medicine 63 Suppl 6: 188-193, 2005

Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxidative Medicine and Cellular Longevity 3(2): 101-108, 2010

New metabolic marker: Advanced glycation end products (AGEs) and receptor for advanced glycation end products (RAGE) system may play a role in the pathogenesis of recurrent pregnancy losses. Journal of Reproductive Immunology 106: 10-11, 2014

Curcumin inhibits advanced glycation end-products AGEs-induced gene expression of receptor for AGEs RAGE in hepatic stellate cells in vitro by elevating PPAR? activity and attenuating oxidative stress. 2012

The role of advanced glycation end-products (AGEs) in the development of vascular diabetic complications. Arquivos Brasileiros de Endocrinologia E Metabologia 52(6): 940-950, 2008